ATOSSA THERAPEUTICS, INC. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
ATOSSA THERAPEUTICS, INC. (ATOS) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 6.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2026-03-31 was 6.00%, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2025-03-31 was 6.00%, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2024-03-31 was 6.00%, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2023-03-31 was 6.00%, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2025 was 6.00%, a 0.00% change from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2024 was 6.00%, a 0.00% change from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2023 was 6.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 3 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 6 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 9 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|---|---|---|
| 2026-06-30 | 6.00% 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 6.00% 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 6.00% 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 6.00% 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 6.00% 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 6.00% 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | 6.00% 10-K · filed 2025-03-25 | |||
| 2024-09-30 | 6.00% 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 6.00% 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | 6.00% 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | 6.00% 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 6.00% 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 6.00% 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 6.00% 10-Q · filed 2023-05-15 | |||
| 2022-09-30 | 6.00% 10-Q · filed 2022-11-07 | |||
| 2022-03-31 | 6.00% 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |